An ecology-and bioassay-guided search employed to discover compounds with activity against tropical parasitic diseases and cancer from the opisthobranch mollusk, Dolabrifera dolabrifera, led to the discovery of antileishmanial properties in the known compound, 5α,8α-epidioxycholest-6-en-3β-ol (1). Compound 1 was identified through nuclear magnetic resonance spectroscopy ( 1 H, 13 C) and mass spectrometry. The compound was concentrated in the digestive gland of D. dolabrifera, but was not detected in other body parts, fecal matter or mucus. Compound 1 showed an IC 50 of 4.9 µM towards the amastigote form of Leishmania donovani compared with an IC 50 of 281 µM towards the control Vero cell line, a 57.3-fold difference, and demonstrated no measurable activity against Plasmodium falciparum, Trypanosoma cruzi, and the breast cancer cell line, MCF-7.
Leishmaniasis is a prevalent disease in many parts of the tropical and subtropical world and is caused by a zoonotic protozoan parasite from the genus Leishmania [1] . Visceral leishmaniasis occurs in 80 countries in Asia and Africa, southern Europe and South America, L. donovani being the pathogen responsible for 90% of the estimated 500,000 new symptomatic cases per year [2] . Drugs currently available for leishmaniasis treatment often show parasite resistance, highly toxic side effects, and prohibitive costs that are commonly incompatible with patients from low-income countries where leishmaniasis is endemic, revealing an urgent need to discover novel treatments for the disease [3] . Just as natural products such as artemisinin have played a pivotal role in the treatment of malaria [4] , compounds from biological sources show significant potential in the treatment of leishmaniasis [5, 6] .
Chemical ecological relationships between tropical organisms in marine and terrestrial environments can facilitate the discovery of novel therapeutic compounds [7] . It was previously shown that extracts from the sea hare, Dolabella auricularia, have potent anticancer properties and later shown that the compound responsible, dolastatin 10, is derived from its cyanobacterial diet [8] . In this study we sought to determine whether chemical ecological relationships between marine organisms could facilitate the search for potential antiparasitic agents.
The sea hare Dolabrifera dolabrifera (Cuvier 1817; Anaspidea: Opisthobranchia) is a common herbivorous opisthobranch that occurs globally in tropical and subtropical oceans and is commonly found in intertidal pools [9] . D. dolabrifera has several forms of physical, behavioral, and chemical defenses. Physically, the presence of a reduced shell may provide some protection, which is complemented by its nocturnal behavior and cryptic coloration [9] . Chemically, a water-soluble extract taken from the mid-gut gland has shown lethality when injected into mice at 200 mg/kg [10] and its egg masses demonstrated activity in an antibacterial zone of inhibition assay [11] . The polypropionate compound, dolabriferol, was isolated from the skin of D. dolabrifera [12] but no studies have been carried out to test the compound's bioactivity.
The epidioxysterol class of compounds contains a sterol nucleus and an endoperoxide moiety and has been documented in a wide variety of marine invertebrates including sea hares, cnidarians,
The compound 5α,8α-epidioxycholest-6-en-3β-ol (1) has been isolated from sea hares in the genus Aplysia, namely from the digestive glands of A. punctata and A. depilans [20] , and from the albumen gland of A. juliana [26] . Compound 1 has also been isolated from other marine organisms including the ascidian, Trididemnum inarmatum [18] , the sea urchin Diadema setosum, [25] , the tunicates Didemnum salary [16] , Cynthia savignyi [14] , and Ascidiella aspersa [20] , the cone snails Conus ebraeus, C. leopardus, and C. tessulatus [15] , and the sponges Ircinia campana [23] , Tethya aurantia [13] , Lendenfeldia chondrodes [27] , Aplysilla glacialis [30] , and Luffariella cf. variabilis [17] . Minh et al. [25] showed that 1 has significant cytotoxicity against the KB human epidermoid carcinoma cell line (IC 50 = 2.0 µg/mL), the FL fibrillary sarcoma of the uterus cell line (IC 50 = 3.93 µg/mL), and the Hep-2 human hepatocellular carcinoma cell line (IC 50 = 2.4 µg/mL). Compound 1 also produces antibacterial zones of inhibition of 6 to 18 mm and antifungal zones of inhibition of 7 to 15 mm [14] .
In the present study we describe the isolation of compound 1 from the ethyl acetate-methanol extract of the digestive gland of D. dolabrifera specimens collected on the coast of Coiba Island in the Republic of Panama. We report a new and significant activity of 1 towards L. donovani and discuss the potential ecological and therapeutic roles of the compound. This is the first reported isolation from the genus Dolabrifera of a compound with potential therapeutic properties.
Bioassay-guided fractionation of the ethyl acetate-methanol extract of the digestive gland of D. dolabrifera yielded a white crystalline solid which was identical to literature values reported for 5α,8αepidioxycholest-6-en-3β-ol (1). The molecular structure was determined by comparing our results with 1 H and 13 C nuclear magnetic resonance (NMR) [13-15, 18, 25] , and 2D (HSQC, HMBC and COSY) NMR spectral data reported in the literature for compound 1 [14, 18, 25] . MS experiments were also consistent with 1 [13, 17, 26, 27] . Analysis by 1 H NMR revealed no evidence of epidioxysterols in other body parts of D. dolabrifera, including the animal's skin, albumen gland, internal organs, or in its mucus or excrement exudates. Mass spectral analyses of the butanol and ethyl acetate extracts of the three species of cyanobacteria collected from the same tidal pools as D. dolabrifera provided no evidence of compound 1 or its precursors.
Compound 1 showed significant in vitro activity towards L. donovani with an IC 50 of 4.9 μM (2.05 μg/mL) ( Table 1) . To determine the cytotoxicity of 1, assays were performed with the mammalian Vero cell line yielding an IC 50 value of 281 μM and a selectivity index of 57.3. Compound 1 demonstrated no measurable activity against Plasmodium falciparum, Trypanosoma cruzi, and against the breast cancer cell line, MCF-7, when tested at concentrations up 10 μg/mL (Table 1) .
We exploited the knowledge that marine invertebrates often employ chemical compounds as a defense against predation to discover a previously unreported activity against visceral leishmaniasis in the known compound 1. That compound 1 was the only detectable component in the digestive gland of D. dolabrifera and the lack of evidence of epidioxysterols in other body parts is in contrast to the results of Jiménez et al. [20] who found that in Aplysia punctata and A. depilans, compound 1, 5α,8α-epidioxycholesta-6,9[11]-dien-3β-ol, and 5α,8α-epidioxycholesta-6,24-dien-3β-ol were distributed throughout the body. Pennings et al. [31] found (-)-7dehydrocholesterol and small amounts of 1 in skin extracts of the sea hare Dolabella auricularia. These results suggest that the presence and distribution of epidioxysterols differ among sea hare genera and/or species within the family Aplysiidae.
Since mass spectral analyses of extracts of three species of cyanobacteria collected from the same tidal pools as D. dolabrifera, including its preferred food source, Moorea producta, showed no evidence of compound 1 or its precursors, our results provide no evidence that the compound is of cyanobacterial origin. Our results are in contrast to those of Gunatilaka et al., who proposed that ∆ 5,7 sterols have a dietary origin due to the differences between the epidioxysterols and their precursors found in different marine invertebrates [13] . Gauvin et al. suggested that because epidioxysterols are commonly found in marine invertebrates, their precursors might be derived from common symbiotic microorganisms [17] .
Since epidioxysterol compounds are widespread among marine invertebrates they may play an important role in marine invertebrate chemical defense [31] , as the extracts of many invertebrates contain cytotoxic [8, 14, 17, 19, 22, 25, 28] , antifouling [27] , and predator deterring properties [29] . Our results suggest that compound 1 may provide a chemical defense for D. dolabrifera. While palatability studies with pellets derived from the skin and body wall of D. dolabrifera suggested low levels of chemical protection [32] , our finding that compound 1 is concentrated in the digestive gland of D. dolabrifera suggests that their study likely overlooked the major source of a compound that could provide chemical defense to the organism.
Márquez et al. [23] found that a fraction of nine 5α, 8αepidioxysterols from the marine sponge Ircinia campana showed antileishmanial activity against amastigotes of Leishmannia [Viannia] panamensis, but no individual compounds were tested for their antileishmanial activity. While the results of Minh et al. [25] indicated that compound 1 has significant cytotoxicity against three tumor cell lines, our results were consistent with those of Ioannou et al. [18] , which did not show significant activity against the breast cancer cell line, MCF-7 (IC 50 > 10 µg/mL).
The mechanism(s) responsible for the biological activity of the sterol endoperoxides is currently unknown. While the mechanism of action of artemisinin is similarly unknown, its antimalarial activity is dependent on the endoperoxide bridge [4, 33, 34] . While compound 1 did not show significant antimalarial activity towards P. falciparum, the endoperoxide bridge could play a role in its toxicity toward the amastigote form of L. donovani although none of the antileishmanial sterols reported to date contain endoperoxide bridges [6] . Due to the low toxicity of steroidal compounds with antileishmanial activity, it has been suggested that synthetic approaches based on this class of compounds should be developed as part of the search for new treatments for leishmaniasis [6] , an observation which is supported by the results of this study.
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Experimental
General: 1 H NMR and 13 C NMR were recorded in chloroform-d 1 (CDCl 3 , 99.8 atom %, Sigma-Aldrich), using a JEOL Eclipse 400 MHz spectrometer. Low resolution mass spectra were measured on a JEOL LC-mate mass spectrometer.
Animal material:
The animals were collected on Coiba Island (07° 23´ 41.7" N, 81° 39´ 03.7" W). Thirty-five D. dolabrifera specimens were collected from the underside of uneven boulders in intertidal pools. They were maintained in 1 L aquaria at ambient temperature, fasted for 24 h to evacuate their digestive system, euthanized in freezing seawater, and stored at -20°C.
Extraction of D. dolabrifera: D. dolabrifera specimens were divided into 7 replicates and dissected into digestive gland, skin (parapodia, foot and head), and body parts (all other internal organs). Replicates were freeze-dried, weighed and pulverized. Ethyl acetate-methanol (1:1, v/v) was added to dried samples, which were then sonicated for 20 min, followed by soaking for 24 h in the solvent mixture. Solvent was removed and the dried samples were re-extracted, sonicated for 5 min, followed by removal of solvent. The solvent mixtures were combined, filtered, and the solvent was removed by rotary evaporation.
Compound isolation:
Initial separation of the compounds present in the digestive gland of D. dolabrifera was carried out using normalphase HPLC with an Econosphere Silica 10 µm column (10 x 250 mm, Altech Associates, Inc.) and an Econosphere silica 5 µm guard column (7.5 x 4.6 mm, Altech Associates, Inc.) with a gradient of 100% hexanes to 100% ethyl acetate over 60 min, monitoring at 260 nm, with a flow rate of 2 mL/min. The mixture of compounds eluting at 37.5 min was further purified by reverse phase HPLC using an XTerra C 18 analytical column (5 µm, 4.6 x 150 mm, Waters Inc.) and a Spherisorb/ODS 2 guard column (5 µm, 4.6 x 30 mm), using a Waters HPLC 600 controller, containing dual pumps (600E), a photodiode array detector (Waters 2996) and a dual wavelength detector (Waters 2487), monitoring at 210 nm and 254 nm, and using an isocratic system of acetonitrile-water (7:3, v/v).
Cyanobacterial material: Three species of cyanobacteria were collected from the same tidal pools as D. dolabrifera: Moorea producta grew as long hair-like filamentous strands, Symploca sp.
grew as small, firm, leaf-like tufts; and Oscillatoria sp. grew as a green buoyant mat. Voucher samples were preserved in ethanol-sea water (7.5:2.5, v/v) at -20°C and extracted as described by Gutiérrez et al. [35] .
Extraction of cyanobacteria:
Samples were freeze-dried, blended, extracted 3 times for 24 h, each in ethyl acetate: methanol (1:1, v/v) and filtered. Extracts were dried, resolubilized in ethyl acetate-water (1:1, v/v). The water layer was removed and extracted with nbutanol-water (3:1, v/v). The n-butanol and ethyl acetate fractions were kept separate and dried by rotary evaporation.
Bioassays: All samples were tested at 10, 2, 0.4, 0.08, and 0.016 µg/mL. The P. falciparum assay is a DNA-based fluorometric assay that uses the W2 strain of the parasite, which is chloroquineresistant [35] . The T. cruzi assay uses a colorimetric method based on amastigotes of a T. cruzi strain expressing β-galactosidase [36] . The L. donovani assay is a DNA-based fluorometric bioassay based on the use of the amastigote form of the parasite [37] . The cancer assay uses the MCF-7 breast cancer cell line in a colorimetric bioassay [38] . The general cytotoxicity assay employs green monkey Vero kidney cells in a colorimetric cell proliferation assay [36] . The selectivity index (SI) was determined by calculating the ratio of the cytotoxicity of 1 against monkey Vero kidney cells.
